Topic

Drug Repurposing

Drug repurposing offers a streamlined pathway to identify new therapeutic applications for established medications. Fillmore and his collaborators utilized gene regulatory network analysis to identify auranofin, an FDA-approved rheumatoid arthritis treatment, as a potential agent for reducing arterial plaque buildup. Their research demonstrates that auranofin inhibits foam cell formation and attenuates inflammation in both animal models and retrospective clinical cohorts, suggesting its utility in the management of coronary artery disease.